Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Helicobacter pylori and Pancreatic Cancer Risk: a Meta-analysis Based on 2,049 Cases and 2,861 Controls

  • Wang, Yin (Postgraduate Training Base of the General Hospital of Jinan Military Command of Liaoning Medical University) ;
  • Zhang, Fu-Cheng (Department of Gastroenterology, the General Hospital of Jinan Military Command) ;
  • Wang, Yao-Jun (Department of Gastroenterology, the General Hospital of Jinan Military Command)
  • Published : 2014.06.15
Download PDF
⟨ Previous Next ⟩

Abstract

Aim: Helicobacter pylori (H. pylori) have been considered as a risk factor for many cancers. We conducted this meta-analysis to clarify the association between H. pylori infection and the risk of pancreatic cancer. Methods: We searched the Medicine/Pubmed and Embase databases, studies about the association between H. pylori infection and pancreatic cancer published up to Jan.2014 were included. Finally, a total of 9 studies were used for this a meta-analysis. The odds ratios (ORs) and 95% confidence interval (95%CI) of H. pylori infection on pancreatic cancer with respect to control groups were evaluated. Two authors independently assessed the methodological quality and extracted data. This meta-analysis was conducted using software, state (version 12.0) to investigate heterogeneity among individual studies and to summarize the studies. Using the fixed-effects or random-effects model, depending on the absence or presence of significant heterogeneity. Sensitivity analysis was performed to assess the influence of each individual study on the pooled ORs by omitting a single study each time. Publication bias was evaluated by funnel plot, using Egger's and Begg's tests. Results: There was no significant association between H. pylori infection and pancreatic cancer risk in the summary ORs,(OR=1.06, 95%CI: 0.74-1.37) through the random-effect method, but heterogeneity among studies was significant ($I^2$=58.9%), so we put the studies into two subgraphs (eastern and western). The results about western (OR=1.14 95%CI:0.89, 1.40) showed heterogeneity among the western countries of $I^2$=6.6%, with no significant association between Hp+ and pancreatic cancer, but the eastern countries (OR=0.62, 95%CI:0.49, 0.76), $I^2$=0, suggested that decreasing pancreas-cancer risk in subjects with Hp+ infection. Simultaneously, 7 studies examined CagA+ strains was (OR=0.84 95%CI:0.63, 1.04), $I^2$=36% with the random-effect method, subgraphs indicated that CagA+ could decrease the risk of pancreatic cancer in the eastern subjects (OR=0.66, 95%CI:0.52-0.80), but the association was not statistically significant in the western subjects (OR=0.95, 95%CI:0.73, 1.16). Conclusion: Hp+ and CagA+ infection are associated with a decreased risk of pancreatic cancer in eastern populations but have no significant associations in western countries.

Keywords

References

  1. Arslan AA, Helzlsouer KJ, Kooperberg C, et al (2010). Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med, 170, 791-802. https://doi.org/10.1001/archinternmed.2010.63
  2. Atherton JC, Blaser MJ (2009). Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J Clin Invest, 119, 2475-87. https://doi.org/10.1172/JCI38605
  3. Aune D, Greenwood DC, Chan DS, et al (2012). Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies. Ann Oncol, 23, 843-52. https://doi.org/10.1093/annonc/mdr398
  4. Ben Q, Xu M, Ning X, et al (2011). Diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies. Eur J Cancer, 47, 1928-37. https://doi.org/10.1016/j.ejca.2011.03.003
  5. Blaser MJ (2006) . Who are we? Indigenous microbes and the ecology of human diseases. EMBO Rep, 7, 956-60. https://doi.org/10.1038/sj.embor.7400812
  6. Blaser MJ, Chen Y, Reibman J (2008). Does Helicobacter pylori protect against asthma and allergy. Gut, 57, 561-7. https://doi.org/10.1136/gut.2007.133462
  7. Chen Y, Blaser MJ (2007). Inverse associations of Helicobacter pylori with asthma and allergy. Arch Intern Med, 167, 821-7. https://doi.org/10.1001/archinte.167.8.821
  8. Chen Y, Blaser MJ (2008). Helicobacter pylori colonization is inversely associated with childhood asthma. J Infect Dis, 198, 553-60. https://doi.org/10.1086/590158
  9. Chen YS, Xu SX, Ding YB, Huang XE, Deng B (2013). Helicobacter pylori infection and the risk of colorectal adenoma and adenocarcinoma: an updated meta-analysis of different testing methods. Asian Pac J Cancer Prev, 14, 7613-9. https://doi.org/10.7314/APJCP.2013.14.12.7613
  10. Correa P, Houghton J (2007). Carcinogenesis of Helicobacter pylori. Gastroenterology, 133, 659-72. https://doi.org/10.1053/j.gastro.2007.06.026
  11. de Martel C, Llosa AE, Friedman GD, et al (2008). Helicobacter pylori infection and development of pancreatic cancer. Cancer Epidermal Biomarkers Prev, 17, 1188-94. https://doi.org/10.1158/1055-9965.EPI-08-0185
  12. Duell EJ, Lucenteforte E, Olson SH, et al (2012). Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol, 23, 2964-70. https://doi.org/10.1093/annonc/mds140
  13. Gawin A, Wex T, Lawniczak M, et al (2012). Helicobacter pylori infection in pancreatic cancer. Pol Merkur Lekarski, 32, 103-7 (in Polish).
  14. Guoqin Yu, Gwen Murphy, Angelika Miche et al (2013). Seropositivity to Helicobacter pylori and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev, 22, 2416-19. https://doi.org/10.1158/1055-9965.EPI-13-0680
  15. Handa O, Naito Y, Yoshikawa T (2011). Redox biology and gastric carcinoge n nesis: the role of Helicobacter pylori. Redox Rep, 16, 1-7. https://doi.org/10.1179/174329211X12968219310756
  16. Harvey A. , Risch, Lingeng Lu, et al (2014). Helicobacter pylori seropositivities and risk of pancreatic carcinoma. Cancer Epidemiol Biomarkers Prev, 23, 172-8. https://doi.org/10.1158/1055-9965.EPI-13-0447
  17. Higashi H, Tsutsumi R, Fujita A, et al (2002). Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci USA, 99, 14428-33. https://doi.org/10.1073/pnas.222375399
  18. Higgins JP, Thompson SG, Deeks JJ, et al (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60. https://doi.org/10.1136/bmj.327.7414.557
  19. Iodice S, Gandini S, Maisonneuve P, et al (2008). Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg, 393, 535-45. https://doi.org/10.1007/s00423-007-0266-2
  20. Iodice S, Maisonneuve P, Botteri E, et al (2010). ABO blood group and cancer. Eur J Cancer, 46, 3345-50. https://doi.org/10.1016/j.ejca.2010.08.009
  21. Larsson S, Orsini N, Wolk A (2007). Body mass index and pancreatic cancer risk: a meta-analysis of prospective studies. Int J Cancer, 120, 1993-8. https://doi.org/10.1002/ijc.22535
  22. Li D, Tang H, Hassan MM, et al (2011). Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies. Cancer Causes Control, 22, 189-97. https://doi.org/10.1007/s10552-010-9686-3
  23. Lindkvist B, Johansen D, Borgstrom A, et al (2008). A prospective study of Helicobacter pylori in relation to the risk for pancreatic cancer. BMC Cancer, 8, 321. https://doi.org/10.1186/1471-2407-8-321
  24. Loh JT, Shaffer CL, Piazuelo MB, et al (2011). Analysis of cagA in Helicobacter pylori strains from Colombian populations with contrasting gastric cancer risk reveals a biomarker for disease severity. Cancer Epidemical Biomarkers Prev, 20, 2237-49. https://doi.org/10.1158/1055-9965.EPI-11-0548
  25. Lucenteforte E, La Vecchia C, Silverman D, et al (2012). Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol, 23, 374-82. https://doi.org/10.1093/annonc/mdr120
  26. Lynch SM, Vrie ling A, Lu bin JH, et al (2009). Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Am J Epidemiol, 170, 403-13. https://doi.org/10.1093/aje/kwp134
  27. Magruder JT, Elahi D, Andersen DK (2011). Diabetes and pancreatic cancer: chicken or egg? Pancreas, 40, 339-51. https://doi.org/10.1097/MPA.0b013e318209e05d
  28. Maisonneuve P, Lowenfels AB (2010). Epidemiology of pancreatic cancer: an update. Dig Dis, 28, 645-56. https://doi.org/10.1159/000320068
  29. Olson SH (2012). Selected medical conditions and risk of pancreatic cancer (review). Mol Carcinog, 51, 75-97. https://doi.org/10.1002/mc.20816
  30. Peek RM, Blaser MJ (2002). Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer, 2, 28-37. https://doi.org/10.1038/nrc703
  31. Raderer M, Wrba F, Kornek G, et al (1997). Association between Helicobacter pylori infection and pancreatic cancer. Oncology, 55, 16-9.
  32. Raimondi S, Lowenfels AB, Morselli-Labate AM, et al (2010). Pancreatic cancer in chronic pancreatitis; a etiology, incidence, and early detection. Best Pract Res Clin Gastroenterol, 24, 349-58. https://doi.org/10.1016/j.bpg.2010.02.007
  33. Risch HA, Yu H, Lu L, et al (2010). ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study. J Natl Cancer Inst, 102, 502- 5. https://doi.org/10.1093/jnci/djq007
  34. Shimoyama T, Takahashi R, Abe D, et al (2010). Serological analysis of Helicobacter hepaticus infection in patients with biliary and pancreatic diseases. J Gastroenterol Hepatol, 25 (Suppl 1), S86-9. https://doi.org/10.1111/j.1440-1746.2010.06224.x
  35. Stolzenberg-Solomon RZ, Blaser MJ, Limburg PJ, et al (2001). Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J Natl Cancer Inst, 93, 937-41. https://doi.org/10.1093/jnci/93.12.937
  36. Tramacere I, Scotti L, Jenab M, et al (2010). Alcohol drinking and pancreatic cancer risk: a meta-analysis of the dose-risk relation. Int J Cancer, 126, 1474-86.
  37. Trikudanathan G, Philip A, Dasanu CA, et al (2011). Association between Helicobacter pylori infection and pancreatic cancer. a cumulative meta-analysis. JOP, 12, 26-31.
  38. Wan-Qing Chen, Di Liang, Si-Wei Zhang, et al (2013). Pancreatic cancer incidence and mortality patterns in China, 2009. Asian Pac J Cancer Prev, 14, 7321-4. https://doi.org/10.7314/APJCP.2013.14.12.7321
  39. Wren AM, Bloom SR (2007). Gut hormones and appetite control. Gastroenterology, 132, 2116-30. https://doi.org/10.1053/j.gastro.2007.03.048
  40. Xiao M, Wang Y, Gao Y (2013). Association between Helicobacter pylori infection and pancreatic cancer development: a meta-analysis. PLoS ONE, 8, e75559. https://doi.org/10.1371/journal.pone.0075559

Cited by

  1. Helicobacter pylori vol.30, pp.6, 2014, https://doi.org/10.1097/MOG.0000000000000128
  2. Cytotoxin-Associated Gene A-Negative Strains of Helicobacter pylori as a Potential Risk Factor of Pancreatic Cancer vol.44, pp.8, 2015, https://doi.org/10.1097/MPA.0000000000000414
  3. infection with oral squamous cell carcinoma vol.45, pp.1, 2015, https://doi.org/10.1111/jop.12324
  4. Helicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain vol.8, pp.1664-302X, 2017, https://doi.org/10.3389/fmicb.2017.00888
  5. Helicobacter pylori infection, atrophic gastritis, and pancreatic cancer risk vol.96, pp.33, 2017, https://doi.org/10.1097/MD.0000000000007811
  6. The skin microbiome and immune system: Potential target for chemoprevention? pp.09054383, 2018, https://doi.org/10.1111/phpp.12334
  7. The role of the vaginal microbiome in gynaecological cancer pp.14700328, 2017, https://doi.org/10.1111/1471-0528.14631
  8. infection, chronic corpus atrophic gastritis and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort: A nested case-control study vol.140, pp.8, 2017, https://doi.org/10.1002/ijc.30590